electroCore, Inc. (ECOR) vs Pulmonx Corporation (LUNG)

electroCore, Inc. and Pulmonx Corporation are both Medical Devices companies. electroCore, Inc. is the larger, with a market value of $102.3M against $81.6M — 1.3× the size. electroCore, Inc. grew revenue faster over the last twelve months: 33.5% against −3.43%. electroCore, Inc. has the higher net margin (−40.0% vs −55.0%) and the higher return on invested capital (0.00% vs −141.0%). Across the 17 metrics below, electroCore, Inc. leads on 12 and Pulmonx Corporation on 5.

Valuation

Metric ECOR LUNG Medical Devices median
P/E n/m n/m 22.18
P/S 2.83 0.93 2.70
P/B n/m 2.07 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 2.72 0.72 2.38
Earnings yield (14.93%) (60.73%) (8.22%)
Free cash flow yield (9.32%) (37.81%) (7.80%)

Profitability

Metric ECOR LUNG Medical Devices median
Gross margin 87.06% 77.06% 56.01%
Operating margin (37.64%) (52.96%) (15.03%)
Net margin (39.96%) (55.03%) (20.40%)
Free cash flow margin (26.36%) (35.07%) (7.24%)
Return on equity 1,761.48% (88.87%) (15.32%)
Return on assets (93.41%) (36.74%) (19.72%)
Return on invested capital 0.00% (141.03%) (10.33%)

Growth

Metric ECOR LUNG Medical Devices median
Revenue growth (TTM) 33.45% (3.43%) 8.80%
EPS growth (last fiscal year) (3.77%) 7.64% —
Revenue growth, 5-year CAGR 55.74% 22.55% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ECOR LUNG Medical Devices median
Debt to equity (2.07) 0.95 0.07
Current ratio 1.21 4.32 2.50
Net debt to EBITDA 0.40 0.62 0.49

Dividend

Metric ECOR LUNG Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric ECOR LUNG Medical Devices median
Market cap 102.33m 81.60m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack